drugset
drugset / Trial / NCT03094403

To Evaluate the Therapeutic Equivalence and Safety of Azelaic Acid 15% Topical Gel

NCT03094403 ↗

Phase 1 Completed 1000 enrolled Sun Pharmaceutical Industries, Inc.
RandomizedParallel-groupSingle-blindTreatment

Summary

A Multi-Center, Double-Blind, Randomized, Placebo Controlled, Parallel-Group Study

Timeline

Start
2016-07-01
Primary completion
2017-03-31
Completion
2017-04-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Azelaic acid Small molecule 15 % Topical

Indications

rosacea